-+ 0.00%
-+ 0.00%
-+ 0.00%

Apotex wins BBB (low) investment-grade issuer rating from Morningstar DBRS

PUBT·07/16/2026 19:30:18
Listen to the news
Apotex wins BBB (low) investment-grade issuer rating from Morningstar DBRS
  • Apotex received an inaugural BBB (low) investment-grade issuer rating from Morningstar DBRS.
  • The rating supported revised pricing and fees under an amended, restated credit agreement.
  • The deal includes term loans, plus a revolving credit facility with capacity of $1.2 billion.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apotex Health Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202607161530PR_NEWS_USPR_____TO06332) on July 16, 2026, and is solely responsible for the information contained therein.